2152-44-5
中文名稱
倍他米松戊酸酯
英文名稱
Betamethasone 17-valerate
CAS
2152-44-5
EINECS 編號
218-439-3
分子式
C27H37FO6
MDL 編號
MFCD00867446
分子量
476.58
MOL 文件
2152-44-5.mol
更新日期
2025/01/10 09:09:20
2152-44-5 結構式
基本信息
中文別名
倍他米松戊酸酯戊酸倍他米松
倍他米松戊酸鹽
7戊酸倍他米松
英文別名
1,4-PREGNADIEN-9-ALPHA-FLUORO-16-BETA-METHYL-11-BETA, 17,21-TRIOL-3,20-DIONE 17-VALERATE1,4-pregnadiene-11b,17a,21-triol-9a-fluoro-16b-methyl-3,20-dione 17-valerate
1,4-PREGNADIENE-11BETA,17ALPHA,21-TRIOL-9ALPHA-FLUORO-16BETA-METHYL-3,20-DIONE 17-VALERATE
9ALPHA-FLUORO-16BETA-METHYL-11BETA,17ALPHA,21-TRIHYDROXY-1,4-PREGNADIENE-3,20-DIONE 17-VALERATE
9ALPHA-FLUORO-16BETA-METHYLPREDNISOLONE 17-VALERATE
9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate
BEDERMIN
BETAMETHASONE 17ALPHA-VALERATE
BETAMETHASONE 17A-VALERATE
BETAMETHASONE 17-VALERATE
BETAMETHASONE VALERATE
BETNESOL-V
BETNEVAL
BETNOVATE
VALISONE
(11-beta,16-beta)-l)oxy)
17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-9-fluoro-11-bet
17-valerate
Betamethasonevalerateester
betnovateat
所屬類別
原料藥：腎上腺皮質激素類藥物理化學性質
外觀性狀倍他米松戊酸酯(2152-44-5)為白色晶體或粉末，比旋光度+75°~+82°
熔點183-184°
比旋光度D +77° (dioxane)
沸點598.9±50.0 °C(Predicted)
密度1.1174 (estimate)
儲存條件2-8°C
溶解度Practically insoluble in water, freely soluble in acetone and in methylene chloride, soluble in ethanol (96 per cent).
酸度系數(pKa)12.90±0.70(Predicted)
形態(tài)neat
顏色白色
Merck13,1183
BRN4240001
InChIKeySNHRLVCMMWUAJD-SUYDQAKGSA-N
SMILES[C@]12(C)C[C@@H]([C@]3(F)[C@@]4(C)C=CC(=O)C=C4CC[C@@]3([H])[C@]1([H])C[C@H](C)[C@@]2(C(=O)CO)OC(=O)CCCC)O |&1:0,3,4,6,16,18,21,23,r|
安全數據
警示詞危險
危險性描述H360D-H373
危險品標志Xn
危險類別碼R48
安全說明S22-S24/25
危險品運輸編號UN 2811 6.1/PG 3
WGK Germany2
RTECS號TU3835000
海關編碼29372290
毒性mouse,LD50,intraperitoneal,632mg/kg (632mg/kg),Shikoku Igaku Zasshi. Shikoku Medical Journal. Vol. 29, Pg. 153, 1973.
常見問題列表
用途
倍他米松戊酸酯主要是用于皮膚類炎癥的外用藥，抑制和減輕皮膚的 瘙癢，紅腫等癥狀，如濕疹，牛皮癬和皮炎。倍他米松戊酸酯屬于高效皮質激素具有易吸收，副作用小的特點。
生物活性
Betamethasone Valerate 是一種中等強效的糖皮質激素類固醇，具有抗炎和免疫抑制特性。靶點
| Target | Value |
|
Glucocorticoid Receptor
() |
體內研究
Betamethasone valerate (10 mg; 5 minutes; applied to the irritated site with a micro spatula) ointment inhibits about 50% of the ear edema without thymus atrophy.
Betamethasone-17-valerate ointment (50 mg) inhibits homologous passive cutaneous anaphylaxis.
| Animal Model: | Female Sprague-Dawley rats weighing 60-70 g (croton oil edema experiment) |
| Dosage: | 10 mg |
| Administration: | Applied to the irritated site with a micro spatula; 5 minutes |
| Result: | Inhibited about 50% of the ear edema without thymus atrophy. |
倍他米松戊酸酯價格(試劑級)
| 報價日期 | 產品編號 | 產品名稱 | CAS號 | 包裝 | 價格 |
| 2024/11/11 | XW21524452 | 倍他米松17-戊酸酯 βmethasone 17-valerate;1,4-pregnadiene-11β,17α,21-triol-9α-fluoro-16β-methyl-3,20-dione 17-valerate;9α-fluoro-16β-methyl-11β,17α,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate;9α-fluoro-16β-methylprednisolone 17-valerate | 2152-44-5 | 5G | 408元 |
| 2024/11/08 | 46493 | 倍他米松戊酸酯 Betamethasone valerate | 2152-44-5 | 1g | 1776元 |
| 2024/11/08 | 46493 | 倍他米松戊酸酯 Betamethasone valerate | 2152-44-5 | 5g | 5738元 |